Renaissance Technologies’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
+14,400
| New | +$1.27M | ﹤0.01% | 2379 |
|
|
2024
Q4 | – | Sell |
-19,400
| Closed | -$1.84M | – | 3834 |
|
|
2024
Q3 | $1.84M | Sell |
19,400
-6,500
| -25% | -$618K | ﹤0.01% | 2074 |
|
|
2024
Q2 | $2.37M | Buy |
25,900
+11,902
| +85% | +$1.09M | ﹤0.01% | 1773 |
|
|
2024
Q1 | $1.27M | Sell |
13,998
-5,602
| -29% | -$508K | ﹤0.01% | 2329 |
|
|
2023
Q4 | $1.6M | Buy |
19,600
+10,400
| +113% | +$846K | ﹤0.01% | 2089 |
|
|
2023
Q3 | $735K | Buy |
9,200
+4,600
| +100% | +$368K | ﹤0.01% | 2505 |
|
|
2023
Q2 | $362K | Sell |
4,600
-2,500
| -35% | -$197K | ﹤0.01% | 3042 |
|
|
2023
Q1 | $551K | Buy |
+7,100
| New | +$551K | ﹤0.01% | 2833 |
|
|
2019
Q2 | – | Sell |
-4,800
| Closed | -$291K | – | 3716 |
|
|
2019
Q1 | $291K | Buy |
4,800
+800
| +20% | +$48.5K | ﹤0.01% | 3104 |
|
|
2018
Q4 | $219K | Buy |
+4,000
| New | +$219K | ﹤0.01% | 3111 |
|